Literature DB >> 12581889

Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo.

Ibane Abasolo1, Luping Yang, Riffat Haleem, Wuhan Xiao, Ruben Pio, Frank Cuttitta, Luis M Montuenga, James M Kozlowski, Alfonso Calvo, Zhou Wang.   

Abstract

The expression of the gene encoding adrenomedullin (AM), a multifunctional peptide hormone, in the prostate is localized to the epithelial cells. Prostate cancer cells are derived from prostatic epithelial cells. To elucidate the potential role of the AM gene in prostate cancer progression, we have stably-transfected the PC3 human prostate cancer cell line with an AM gene expression vector. The AM-transfected PC3 sublines were studied along with parental and empty vector transfected PC3 cells as controls. The average level of AM in the conditioned media of AM-transfected cells was 0.959+/-0.113 nM, a physiologically relevant concentration. The ectopic expression of AM gene inhibited the proliferation of PC3 cells in culture dishes. In addition, anchorage-independent growth of the transfected sublines was virtually abolished in soft agar assays. Flow cytometry studies showed that overexpression of AM gene caused a very significant G(1)/G(0) cell cycle arrest. In vivo experiments demonstrated that AM gene expression markedly inhibited the growth of xenograft tumors in nude mice. Our in vivo and in vitro studies suggest that AM could strongly suppress the malignancy of prostate cancer cells, via autocrine and/or paracrine mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581889     DOI: 10.1016/s0303-7207(02)00229-0

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  4 in total

1.  Prolongation of off-cycle interval by finasteride is not associated with survival improvement in intermittent androgen deprivation therapy in LNCaP tumor model.

Authors:  Yujuan Wang; Shubham Gupta; Vi Hua; Raquel Ramos-Garcia; Daniel Shevrin; Borko D Jovanovic; Joel B Nelson; Zhou Wang
Journal:  Prostate       Date:  2010-02-01       Impact factor: 4.104

Review 2.  Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research.

Authors:  Rahul A Parikh; Laura E Pascal; Benjamin J Davies; Zhou Wang
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

3.  Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.

Authors:  Bharat H Joshi; Pamela Leland; Alfonso Calvo; Jeffrey E Green; Raj K Puri
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 13.312

4.  Characterization of prostate cancer cell progression in zebrafish xenograft model.

Authors:  Wei Xu; Brittany A Foster; Mackenzie Richards; Kenneth R Bondioli; Girish Shah; Christopher C Green
Journal:  Int J Oncol       Date:  2017-11-06       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.